ReP USP - Resultado da busca

Artigo de periodico
Reporting rates of opioid‑related adverse events since 1965 in Canada: a descriptive retrospective study (2021)
Lavallée, Maude; Silveira, Carolina Galli da ; Akinola, Samuel; Méthot, Julie; Piché, Marie\2011Eve; Bérard, Anick; Thibault, Magalie; Gonella, Jennifer Midiani; Sousa, Fernanda Raphael Escobar Gimenes de ; Leclerc, Jacinthe
Source: Drugs - Real World Outcomes. Unidade: EERP
Subjects: ÓPIO, FÁRMACOS PSICOTRÓPICOS, DOR CRÔNICA, PACIENTES AMBULATORIAIS, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAVALLÉE, Maude et al. Reporting rates of opioid‑related adverse events since 1965 in Canada: a descriptive retrospective study. Drugs - Real World Outcomes, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.1007/s40801-021-00275-2. Acesso em: 11 nov. 2024.
APA
Lavallée, M., Silveira, C. G. da, Akinola, S., Méthot, J., Piché, M. \2011E., Bérard, A., et al. (2021). Reporting rates of opioid‑related adverse events since 1965 in Canada: a descriptive retrospective study. Drugs - Real World Outcomes, 1-12. doi:10.1007/s40801-021-00275-2
NLM
Lavallée M, Silveira CG da, Akinola S, Méthot J, Piché M\2011E, Bérard A, Thibault M, Gonella JM, Sousa FREG de, Leclerc J. Reporting rates of opioid‑related adverse events since 1965 in Canada: a descriptive retrospective study [Internet]. Drugs - Real World Outcomes. 2021 ; 1-12.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1007/s40801-021-00275-2
Vancouver
Lavallée M, Silveira CG da, Akinola S, Méthot J, Piché M\2011E, Bérard A, Thibault M, Gonella JM, Sousa FREG de, Leclerc J. Reporting rates of opioid‑related adverse events since 1965 in Canada: a descriptive retrospective study [Internet]. Drugs - Real World Outcomes. 2021 ; 1-12.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1007/s40801-021-00275-2
Trabalho de evento-resumo periodico
Can we use the canadian postmarketing spontaneous pharmacovigilance system for cardiovascular drug safety research? (2020)
Akinola, Pelumi Samuel; Silveira, Carolina Galli da ; Corbin, Sonia; Lavallée, Maude; Thibault, Magalie; Gonella, Jennifer Midiani; Sousa, Fernanda Raphael Escobar Gimenes de ; Leclerc, Jacinthe
Source: Canadian Journal of Cardiology. Conference titles: Canadian Cardiovascular Congress (CCC). Unidade: EERP
Subjects: FARMACOVIGILÂNCIA, MEDICAMENTO, FÁRMACOS (SISTEMA CARDIOVASCULAR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AKINOLA, Pelumi Samuel et al. Can we use the canadian postmarketing spontaneous pharmacovigilance system for cardiovascular drug safety research?. Canadian Journal of Cardiology. New York: Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.cjca.2020.07.166. Acesso em: 11 nov. 2024. , 2020
APA
Akinola, P. S., Silveira, C. G. da, Corbin, S., Lavallée, M., Thibault, M., Gonella, J. M., et al. (2020). Can we use the canadian postmarketing spontaneous pharmacovigilance system for cardiovascular drug safety research? Canadian Journal of Cardiology. New York: Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.cjca.2020.07.166
NLM
Akinola PS, Silveira CG da, Corbin S, Lavallée M, Thibault M, Gonella JM, Sousa FREG de, Leclerc J. Can we use the canadian postmarketing spontaneous pharmacovigilance system for cardiovascular drug safety research? [Internet]. Canadian Journal of Cardiology. 2020 ; 36( 10): S83-S84.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.cjca.2020.07.166
Vancouver
Akinola PS, Silveira CG da, Corbin S, Lavallée M, Thibault M, Gonella JM, Sousa FREG de, Leclerc J. Can we use the canadian postmarketing spontaneous pharmacovigilance system for cardiovascular drug safety research? [Internet]. Canadian Journal of Cardiology. 2020 ; 36( 10): S83-S84.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.cjca.2020.07.166
Artigo de periodico
Using data from the Canadian post-marketing spontaneous pharmacovigilance system for drug safety research: a feasibility study (2020)
Akinola, Pelumi Samuel; Silveira, Carolina Galli da ; Corbin, Sonia; Lavallée, Maude; Thibault, Magalie; Gonella, Jennifer Midiani; Sousa, Fernanda Raphael Escobar Gimenes de ; Leclerc, Jacinthe
Source: Pharmaceutical Medicine. Unidade: EERP
Subjects: ANTAGONISMO DE DROGAS, ANTICOAGULANTES, VIGILÂNCIA DE PRODUTOS COMERCIALIZADOS, FARMACOVIGILÂNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AKINOLA, Pelumi Samuel et al. Using data from the Canadian post-marketing spontaneous pharmacovigilance system for drug safety research: a feasibility study. Pharmaceutical Medicine, v. 34, n. 4, p. 263-269, 2020Tradução . . Disponível em: https://doi.org/10.1007/s40290-020-00345-w. Acesso em: 11 nov. 2024.
APA
Akinola, P. S., Silveira, C. G. da, Corbin, S., Lavallée, M., Thibault, M., Gonella, J. M., et al. (2020). Using data from the Canadian post-marketing spontaneous pharmacovigilance system for drug safety research: a feasibility study. Pharmaceutical Medicine, 34( 4), 263-269. doi:10.1007/s40290-020-00345-w
NLM
Akinola PS, Silveira CG da, Corbin S, Lavallée M, Thibault M, Gonella JM, Sousa FREG de, Leclerc J. Using data from the Canadian post-marketing spontaneous pharmacovigilance system for drug safety research: a feasibility study [Internet]. Pharmaceutical Medicine. 2020 ; 34( 4): 263-269.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1007/s40290-020-00345-w
Vancouver
Akinola PS, Silveira CG da, Corbin S, Lavallée M, Thibault M, Gonella JM, Sousa FREG de, Leclerc J. Using data from the Canadian post-marketing spontaneous pharmacovigilance system for drug safety research: a feasibility study [Internet]. Pharmaceutical Medicine. 2020 ; 34( 4): 263-269.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1007/s40290-020-00345-w

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation